Monday, April 01, 2024 3:13:47 PM
Did you read the 3/28 news from the compay?
Seems like the market is looking to chase the price up.
GLTU
GO4AWILDRIDE
STOCK MARKET SUCKS
Recent ANTX News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 11:42:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 11:40:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 11:38:58 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/23/2024 11:32:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/11/2024 01:46:19 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/28/2024 12:07:58 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/21/2024 11:00:10 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/19/2024 01:51:42 AM
- AN2 Therapeutics to Participate at Upcoming Investor Conferences • Business Wire • 11/14/2024 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2024 09:04:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2024 09:02:00 PM
- AN2 Therapeutics Reports Third Quarter 2024 Financial Results, Provides Important EBO-301 Update and Highlights Progress Across Boron Chemistry Pipeline • Business Wire • 11/13/2024 09:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 09:57:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 09:51:24 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 11/05/2024 09:49:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/05/2024 09:05:32 PM
- AN2 Therapeutics Receives Continuation Grant to Discover Novel Boron Based Therapies for Tuberculosis (caused by Mycobacterium tuberculosis) and Malaria • Business Wire • 10/17/2024 11:00:00 AM
- AN2 Therapeutics to Present at the H.C. Wainwright 26th Annual Global Investment Conference • Business Wire • 08/28/2024 08:00:00 PM
- Form 8-A12B - Registration of securities [Section 12(b)] • Edgar (US Regulatory) • 08/19/2024 10:07:48 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/19/2024 10:04:59 AM
- AN2 Therapeutics Adopts Limited Duration Stockholder Rights Plan • Business Wire • 08/16/2024 11:00:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/13/2024 08:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/13/2024 08:06:10 PM
- AN2 Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business and Scientific Highlights • Business Wire • 08/13/2024 08:01:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 08:50:01 PM
The Crypto Company Highlights Blockchain Training Alliance's Successes and Momentum for 2025 • CRCW • Dec 26, 2024 8:58 AM
Hertz Energy Provides Antimony and Critical Minerals Projects Update and Announces Financing • HZLIF • Dec 20, 2024 9:00 AM
North Bay Resources Announces Arrival of 42 Tons Gold Ore at Bishop Gold Mill, California • NBRI • Dec 20, 2024 9:00 AM
Consumer Automotive Finance Subsidiary Drago Knives Narrows Down Potential Partner to Manufacture Patented Throwing Knives • CAFI • Dec 20, 2024 9:00 AM
$ASNS - Is this the Next Big Cybersecurity Stock? How Actelis Networks is Revolutionizing Critical Infrastructure Protection • ASNS • Dec 20, 2024 8:50 AM
UAV Corp's (UMAV), Skyborne Technology to Build "SKY" Hangar at Its Costin Airport Scheduled for Groundbreaking Ceremony Winter 2025 • UMAV • Dec 20, 2024 8:30 AM